Myomo, Inc. (MYO) vs Rapid Micro Biosystems, Inc. (RPID)
Myomo, Inc. and Rapid Micro Biosystems, Inc. are both Medical Devices companies. Myomo, Inc. is the larger, with a market value of $64.6M against $55.7M — 1.2× the size. Rapid Micro Biosystems, Inc. grew revenue faster over the last twelve months: 16.1% against 6.14%. Myomo, Inc. has the higher net margin (−33.5% vs −145.6%) and the higher return on invested capital (−167.9% vs −181.6%). Across the 18 metrics below, Myomo, Inc. leads on 10 and Rapid Micro Biosystems, Inc. on 8.
Valuation
Profitability
| Metric | MYO | RPID | Medical Devices median |
|---|---|---|---|
| Gross margin | 68.35% | 5.55% | 56.01% |
| Operating margin | (27.05%) | (141.45%) | (15.03%) |
| Net margin | (33.53%) | (145.55%) | (20.40%) |
| Free cash flow margin | (21.01%) | (114.83%) | (7.24%) |
| Return on equity | (123.76%) | (141.65%) | (15.32%) |
| Return on assets | (39.20%) | (76.40%) | (19.72%) |
| Return on invested capital | (167.90%) | (181.64%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack